Search Tag: Abbott

Executive Health Management

Elevating the clinical laboratory’s role in healthcare delivery

2018 21 Aug

David Humphreys  Global Head of Health Policy,  The Economist Intelligence Unit (EIU) Abbott recently commissioned a study by the Economist Intelligence Unit – supported by research partners IPSOS and Acuity – to examine the laboratory’s current influence and perception, as well as to explore initiatives that could increase the impact of... Read more

Executive Health Management

Changing the status quo – big data and disruptive technologies

2018 21 Aug

Utilizing big data for better care Jan-Philipp Beck                                                        &nbs Read more

ICU Management

Abbott Announces CE Mark For its "Alinity S" Blood and Plasma Screening System

2017 12 Jan

Abbott has announced its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other countries that recognize CE Mark. The new testing solution is designed to screen blood and plasma faster and more efficiently within a smaller footprint than Abbott's current systems. In a testing specialty that can require extensive... Read more

ICU Management

Establishment of Ambulatory Emergency Services at James Paget University Hospital

2016 09 Dec

INTRODUCTION   A study of emergency admissions in England found that over a quarter of admissions did not require an overnight stay (length of stay [LoS] of zero). 1  This suggests that many emergency patients could benefit from ambulatory emergency care (AEC). 1   Fundamental to AEC is the identification and management of patients with... Read more

Cardiology Management

Abbott To Take Over St Jude in $25 bln Mega-Cardio Deal

2016 28 Apr

Abbott Laboratories is taking over St. Jude Medical Inc. in a deal worth $25 bln that will create a giant in the cardio-related devices market. The two NYSE-listed companies said in a joint announcement that the combination will “create a premier medical device leader and strengthen Abbott’s long-term growth potential.” They added that the... Read more

ICU Management

Abbott to Acquire Alere,Becoming Leader in Point of Care Testing & Advancing Global Diagnostics

2016 18 Feb

ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS - Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close - Acquisition will provide access to new product applications, channels and geographies -... Read more

ICU Management

Rapid Pathogen Testing With PCR/ESI-MS In Practice

2015 31 Dec

Kristoffer Strålin, MD, PhD , is Associate Professor and Senior Consultant at the Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden. Karolinska Institute is a world renowned medical university, which has the mission of improving people’s health through research and education. Together with Karolinska University Hospital,... Read more

ICU Management

Innovation To ID Infection Source Without Blood Culture

2014 16 Sep

A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately  $2.2 million  (€1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly... Read more

Executive Health Management

Abbott Tops Industry List for Economic and Social Performance

2014 15 Sep

Abbott, a global healthcare organisation, has been named the second leading company in the pharmaceutical industry by the Dow Jones Sustainability Index (DJSI) for the second consecutive year. This is one of the most prestigious global benchmarks for corporate responsibility and sustainability. Abbott is an industry group leader in healthcare... Read more

ICU Management

Oral Nutritional Supplements in the Hospital Demonstrate Significant Health & Cost Benefits

2013 04 Sep

A recent health economics and outcomes study, conducted by leading health economists and supported by Abbott, found that oral nutritional supplements provided to patients during hospitalization were associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for... Read more